Preliminary Assessment of the Anti-inflammatory Activity of New Structural Honokiol Analogs with a 4'- O -(2-Fluoroethyl) Moiety and the Potential of Their 18 F-Labeled Derivatives for Neuroinflammation Imaging

Neolignans honokiol and 4'- -methylhonokiol (MH) and their derivatives have pronounced anti-inflammatory activity, as evidenced by numerous pharmacological studies. Literature data suggested that cyclooxygenase type 2 (COX-2) may be a target for these compounds in vitro and in vivo. Recent stud...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecules (Basel, Switzerland) Switzerland), 2021-11, Vol.26 (21)
Hauptverfasser: Vaulina, Daria D, Stosman, Kira I, Sivak, Konstantin V, Aleksandrov, Andrey G, Viktorov, Nikolai B, Kuzmich, Nikolay N, Kiseleva, Mariia M, Kuznetsova, Olga F, Gomzina, Natalia A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 21
container_start_page
container_title Molecules (Basel, Switzerland)
container_volume 26
creator Vaulina, Daria D
Stosman, Kira I
Sivak, Konstantin V
Aleksandrov, Andrey G
Viktorov, Nikolai B
Kuzmich, Nikolay N
Kiseleva, Mariia M
Kuznetsova, Olga F
Gomzina, Natalia A
description Neolignans honokiol and 4'- -methylhonokiol (MH) and their derivatives have pronounced anti-inflammatory activity, as evidenced by numerous pharmacological studies. Literature data suggested that cyclooxygenase type 2 (COX-2) may be a target for these compounds in vitro and in vivo. Recent studies of [ C]MPbP ( ) biodistribution in LPS (lipopolysaccharide)-treated rats have confirmed the high potential of MH derivatives for imaging neuroinflammation. Here, we report the synthesis of four structural analogs of honokiol, of which ( ) was selected for labeling with fluorine-18 (T = 109.8 min) due to its high anti-inflammatory activity confirmed by enzyme immunoassays (EIA) and neuromorphological studies. The high inhibitory potency of to COX-2 and its moderate lipophilicity and chemical stability are favorable factors for the preliminary evaluation of the radioligand in a rodent model of neuroinflammation. was prepared with good radiochemical yield and high molar activity and radiochemical purity by F-fluoroethylation of the precursor with Boc-protecting group ( ) with [ F]2-fluoro-1-bromoethane ([ F]FEB). Ex vivo biodistribution studies revealed a small to moderate increase in radioligand uptake in the brain and peripheral organs of LPS-induced rats compared to control animals. Pretreatment with celecoxib resulted in significant blocking of radioactivity uptake in the brain (pons and medulla), heart, lungs, and kidneys, indicating that is likely to specifically bind to COX-2 in a rat model of neuroinflammation. However, in comparison with [ C]MPbP, the new radioligand showed decreased brain uptake in LPS rats and high retention in the blood pool, which apparently could be explained by its high plasma protein binding. We believe that the structure of can be optimized by replacing the substituents in the biphenyl core to eliminate these disadvantages and develop new radioligands for imaging activated microglia.
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_34771039</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>34771039</sourcerecordid><originalsourceid>FETCH-pubmed_primary_347710393</originalsourceid><addsrcrecordid>eNqFkE1LAzEQhoMgtlb_gsxNPQT2S2qPRV1a8KNg7yXtzu6OJpmSZFv2b_qLTEW99jSXZ95n5j0Rw7TIEpknxWQgzr3_SJIsLdK7MzHIi_E4TfLJUHwtHGoyZJXrYeo9em_QBuAaQoswtYEk2VorY1TgA7MJtKPQH4hX3MN7cN0mdE5pmLHlT2Idt5TmxsOeQgsKimsJbyBvMlnqjh1jaHt9Cy9MGHOUrX5UCw5RTDEnJi9bJAfpPZTyWa1RYwWP6Ginohw91OyivHP8fxqxhblRDdnmQpzWSnu8_J0jcVU-LR9mctutDVarrSMTv139lZAfBb4B1i5qbQ</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Preliminary Assessment of the Anti-inflammatory Activity of New Structural Honokiol Analogs with a 4'- O -(2-Fluoroethyl) Moiety and the Potential of Their 18 F-Labeled Derivatives for Neuroinflammation Imaging</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Vaulina, Daria D ; Stosman, Kira I ; Sivak, Konstantin V ; Aleksandrov, Andrey G ; Viktorov, Nikolai B ; Kuzmich, Nikolay N ; Kiseleva, Mariia M ; Kuznetsova, Olga F ; Gomzina, Natalia A</creator><creatorcontrib>Vaulina, Daria D ; Stosman, Kira I ; Sivak, Konstantin V ; Aleksandrov, Andrey G ; Viktorov, Nikolai B ; Kuzmich, Nikolay N ; Kiseleva, Mariia M ; Kuznetsova, Olga F ; Gomzina, Natalia A</creatorcontrib><description>Neolignans honokiol and 4'- -methylhonokiol (MH) and their derivatives have pronounced anti-inflammatory activity, as evidenced by numerous pharmacological studies. Literature data suggested that cyclooxygenase type 2 (COX-2) may be a target for these compounds in vitro and in vivo. Recent studies of [ C]MPbP ( ) biodistribution in LPS (lipopolysaccharide)-treated rats have confirmed the high potential of MH derivatives for imaging neuroinflammation. Here, we report the synthesis of four structural analogs of honokiol, of which ( ) was selected for labeling with fluorine-18 (T = 109.8 min) due to its high anti-inflammatory activity confirmed by enzyme immunoassays (EIA) and neuromorphological studies. The high inhibitory potency of to COX-2 and its moderate lipophilicity and chemical stability are favorable factors for the preliminary evaluation of the radioligand in a rodent model of neuroinflammation. was prepared with good radiochemical yield and high molar activity and radiochemical purity by F-fluoroethylation of the precursor with Boc-protecting group ( ) with [ F]2-fluoro-1-bromoethane ([ F]FEB). Ex vivo biodistribution studies revealed a small to moderate increase in radioligand uptake in the brain and peripheral organs of LPS-induced rats compared to control animals. Pretreatment with celecoxib resulted in significant blocking of radioactivity uptake in the brain (pons and medulla), heart, lungs, and kidneys, indicating that is likely to specifically bind to COX-2 in a rat model of neuroinflammation. However, in comparison with [ C]MPbP, the new radioligand showed decreased brain uptake in LPS rats and high retention in the blood pool, which apparently could be explained by its high plasma protein binding. We believe that the structure of can be optimized by replacing the substituents in the biphenyl core to eliminate these disadvantages and develop new radioligands for imaging activated microglia.</description><identifier>EISSN: 1420-3049</identifier><identifier>PMID: 34771039</identifier><language>eng</language><publisher>Switzerland</publisher><subject>Animals ; Anti-Inflammatory Agents - chemical synthesis ; Anti-Inflammatory Agents - chemistry ; Biphenyl Compounds - chemical synthesis ; Biphenyl Compounds - chemistry ; Fluorine Radioisotopes ; Hydrocarbons, Fluorinated - chemistry ; Inflammation - diagnostic imaging ; Lignans - chemical synthesis ; Lignans - chemistry ; Male ; Mice ; Mice, Inbred C57BL ; Radiopharmaceuticals - chemical synthesis ; Radiopharmaceuticals - chemistry</subject><ispartof>Molecules (Basel, Switzerland), 2021-11, Vol.26 (21)</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-8369-2537 ; 0000-0003-4064-5033 ; 0000-0003-1088-2396</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34771039$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vaulina, Daria D</creatorcontrib><creatorcontrib>Stosman, Kira I</creatorcontrib><creatorcontrib>Sivak, Konstantin V</creatorcontrib><creatorcontrib>Aleksandrov, Andrey G</creatorcontrib><creatorcontrib>Viktorov, Nikolai B</creatorcontrib><creatorcontrib>Kuzmich, Nikolay N</creatorcontrib><creatorcontrib>Kiseleva, Mariia M</creatorcontrib><creatorcontrib>Kuznetsova, Olga F</creatorcontrib><creatorcontrib>Gomzina, Natalia A</creatorcontrib><title>Preliminary Assessment of the Anti-inflammatory Activity of New Structural Honokiol Analogs with a 4'- O -(2-Fluoroethyl) Moiety and the Potential of Their 18 F-Labeled Derivatives for Neuroinflammation Imaging</title><title>Molecules (Basel, Switzerland)</title><addtitle>Molecules</addtitle><description>Neolignans honokiol and 4'- -methylhonokiol (MH) and their derivatives have pronounced anti-inflammatory activity, as evidenced by numerous pharmacological studies. Literature data suggested that cyclooxygenase type 2 (COX-2) may be a target for these compounds in vitro and in vivo. Recent studies of [ C]MPbP ( ) biodistribution in LPS (lipopolysaccharide)-treated rats have confirmed the high potential of MH derivatives for imaging neuroinflammation. Here, we report the synthesis of four structural analogs of honokiol, of which ( ) was selected for labeling with fluorine-18 (T = 109.8 min) due to its high anti-inflammatory activity confirmed by enzyme immunoassays (EIA) and neuromorphological studies. The high inhibitory potency of to COX-2 and its moderate lipophilicity and chemical stability are favorable factors for the preliminary evaluation of the radioligand in a rodent model of neuroinflammation. was prepared with good radiochemical yield and high molar activity and radiochemical purity by F-fluoroethylation of the precursor with Boc-protecting group ( ) with [ F]2-fluoro-1-bromoethane ([ F]FEB). Ex vivo biodistribution studies revealed a small to moderate increase in radioligand uptake in the brain and peripheral organs of LPS-induced rats compared to control animals. Pretreatment with celecoxib resulted in significant blocking of radioactivity uptake in the brain (pons and medulla), heart, lungs, and kidneys, indicating that is likely to specifically bind to COX-2 in a rat model of neuroinflammation. However, in comparison with [ C]MPbP, the new radioligand showed decreased brain uptake in LPS rats and high retention in the blood pool, which apparently could be explained by its high plasma protein binding. We believe that the structure of can be optimized by replacing the substituents in the biphenyl core to eliminate these disadvantages and develop new radioligands for imaging activated microglia.</description><subject>Animals</subject><subject>Anti-Inflammatory Agents - chemical synthesis</subject><subject>Anti-Inflammatory Agents - chemistry</subject><subject>Biphenyl Compounds - chemical synthesis</subject><subject>Biphenyl Compounds - chemistry</subject><subject>Fluorine Radioisotopes</subject><subject>Hydrocarbons, Fluorinated - chemistry</subject><subject>Inflammation - diagnostic imaging</subject><subject>Lignans - chemical synthesis</subject><subject>Lignans - chemistry</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Radiopharmaceuticals - chemical synthesis</subject><subject>Radiopharmaceuticals - chemistry</subject><issn>1420-3049</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1LAzEQhoMgtlb_gsxNPQT2S2qPRV1a8KNg7yXtzu6OJpmSZFv2b_qLTEW99jSXZ95n5j0Rw7TIEpknxWQgzr3_SJIsLdK7MzHIi_E4TfLJUHwtHGoyZJXrYeo9em_QBuAaQoswtYEk2VorY1TgA7MJtKPQH4hX3MN7cN0mdE5pmLHlT2Idt5TmxsOeQgsKimsJbyBvMlnqjh1jaHt9Cy9MGHOUrX5UCw5RTDEnJi9bJAfpPZTyWa1RYwWP6Ginohw91OyivHP8fxqxhblRDdnmQpzWSnu8_J0jcVU-LR9mctutDVarrSMTv139lZAfBb4B1i5qbQ</recordid><startdate>20211101</startdate><enddate>20211101</enddate><creator>Vaulina, Daria D</creator><creator>Stosman, Kira I</creator><creator>Sivak, Konstantin V</creator><creator>Aleksandrov, Andrey G</creator><creator>Viktorov, Nikolai B</creator><creator>Kuzmich, Nikolay N</creator><creator>Kiseleva, Mariia M</creator><creator>Kuznetsova, Olga F</creator><creator>Gomzina, Natalia A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><orcidid>https://orcid.org/0000-0002-8369-2537</orcidid><orcidid>https://orcid.org/0000-0003-4064-5033</orcidid><orcidid>https://orcid.org/0000-0003-1088-2396</orcidid></search><sort><creationdate>20211101</creationdate><title>Preliminary Assessment of the Anti-inflammatory Activity of New Structural Honokiol Analogs with a 4'- O -(2-Fluoroethyl) Moiety and the Potential of Their 18 F-Labeled Derivatives for Neuroinflammation Imaging</title><author>Vaulina, Daria D ; Stosman, Kira I ; Sivak, Konstantin V ; Aleksandrov, Andrey G ; Viktorov, Nikolai B ; Kuzmich, Nikolay N ; Kiseleva, Mariia M ; Kuznetsova, Olga F ; Gomzina, Natalia A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmed_primary_347710393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Animals</topic><topic>Anti-Inflammatory Agents - chemical synthesis</topic><topic>Anti-Inflammatory Agents - chemistry</topic><topic>Biphenyl Compounds - chemical synthesis</topic><topic>Biphenyl Compounds - chemistry</topic><topic>Fluorine Radioisotopes</topic><topic>Hydrocarbons, Fluorinated - chemistry</topic><topic>Inflammation - diagnostic imaging</topic><topic>Lignans - chemical synthesis</topic><topic>Lignans - chemistry</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Radiopharmaceuticals - chemical synthesis</topic><topic>Radiopharmaceuticals - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vaulina, Daria D</creatorcontrib><creatorcontrib>Stosman, Kira I</creatorcontrib><creatorcontrib>Sivak, Konstantin V</creatorcontrib><creatorcontrib>Aleksandrov, Andrey G</creatorcontrib><creatorcontrib>Viktorov, Nikolai B</creatorcontrib><creatorcontrib>Kuzmich, Nikolay N</creatorcontrib><creatorcontrib>Kiseleva, Mariia M</creatorcontrib><creatorcontrib>Kuznetsova, Olga F</creatorcontrib><creatorcontrib>Gomzina, Natalia A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Molecules (Basel, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vaulina, Daria D</au><au>Stosman, Kira I</au><au>Sivak, Konstantin V</au><au>Aleksandrov, Andrey G</au><au>Viktorov, Nikolai B</au><au>Kuzmich, Nikolay N</au><au>Kiseleva, Mariia M</au><au>Kuznetsova, Olga F</au><au>Gomzina, Natalia A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Preliminary Assessment of the Anti-inflammatory Activity of New Structural Honokiol Analogs with a 4'- O -(2-Fluoroethyl) Moiety and the Potential of Their 18 F-Labeled Derivatives for Neuroinflammation Imaging</atitle><jtitle>Molecules (Basel, Switzerland)</jtitle><addtitle>Molecules</addtitle><date>2021-11-01</date><risdate>2021</risdate><volume>26</volume><issue>21</issue><eissn>1420-3049</eissn><abstract>Neolignans honokiol and 4'- -methylhonokiol (MH) and their derivatives have pronounced anti-inflammatory activity, as evidenced by numerous pharmacological studies. Literature data suggested that cyclooxygenase type 2 (COX-2) may be a target for these compounds in vitro and in vivo. Recent studies of [ C]MPbP ( ) biodistribution in LPS (lipopolysaccharide)-treated rats have confirmed the high potential of MH derivatives for imaging neuroinflammation. Here, we report the synthesis of four structural analogs of honokiol, of which ( ) was selected for labeling with fluorine-18 (T = 109.8 min) due to its high anti-inflammatory activity confirmed by enzyme immunoassays (EIA) and neuromorphological studies. The high inhibitory potency of to COX-2 and its moderate lipophilicity and chemical stability are favorable factors for the preliminary evaluation of the radioligand in a rodent model of neuroinflammation. was prepared with good radiochemical yield and high molar activity and radiochemical purity by F-fluoroethylation of the precursor with Boc-protecting group ( ) with [ F]2-fluoro-1-bromoethane ([ F]FEB). Ex vivo biodistribution studies revealed a small to moderate increase in radioligand uptake in the brain and peripheral organs of LPS-induced rats compared to control animals. Pretreatment with celecoxib resulted in significant blocking of radioactivity uptake in the brain (pons and medulla), heart, lungs, and kidneys, indicating that is likely to specifically bind to COX-2 in a rat model of neuroinflammation. However, in comparison with [ C]MPbP, the new radioligand showed decreased brain uptake in LPS rats and high retention in the blood pool, which apparently could be explained by its high plasma protein binding. We believe that the structure of can be optimized by replacing the substituents in the biphenyl core to eliminate these disadvantages and develop new radioligands for imaging activated microglia.</abstract><cop>Switzerland</cop><pmid>34771039</pmid><orcidid>https://orcid.org/0000-0002-8369-2537</orcidid><orcidid>https://orcid.org/0000-0003-4064-5033</orcidid><orcidid>https://orcid.org/0000-0003-1088-2396</orcidid></addata></record>
fulltext fulltext
identifier EISSN: 1420-3049
ispartof Molecules (Basel, Switzerland), 2021-11, Vol.26 (21)
issn 1420-3049
language eng
recordid cdi_pubmed_primary_34771039
source MEDLINE; DOAJ Directory of Open Access Journals; MDPI - Multidisciplinary Digital Publishing Institute; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry
subjects Animals
Anti-Inflammatory Agents - chemical synthesis
Anti-Inflammatory Agents - chemistry
Biphenyl Compounds - chemical synthesis
Biphenyl Compounds - chemistry
Fluorine Radioisotopes
Hydrocarbons, Fluorinated - chemistry
Inflammation - diagnostic imaging
Lignans - chemical synthesis
Lignans - chemistry
Male
Mice
Mice, Inbred C57BL
Radiopharmaceuticals - chemical synthesis
Radiopharmaceuticals - chemistry
title Preliminary Assessment of the Anti-inflammatory Activity of New Structural Honokiol Analogs with a 4'- O -(2-Fluoroethyl) Moiety and the Potential of Their 18 F-Labeled Derivatives for Neuroinflammation Imaging
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T16%3A17%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Preliminary%20Assessment%20of%20the%20Anti-inflammatory%20Activity%20of%20New%20Structural%20Honokiol%20Analogs%20with%20a%204'-%20O%20-(2-Fluoroethyl)%20Moiety%20and%20the%20Potential%20of%20Their%2018%20F-Labeled%20Derivatives%20for%20Neuroinflammation%20Imaging&rft.jtitle=Molecules%20(Basel,%20Switzerland)&rft.au=Vaulina,%20Daria%20D&rft.date=2021-11-01&rft.volume=26&rft.issue=21&rft.eissn=1420-3049&rft_id=info:doi/&rft_dat=%3Cpubmed%3E34771039%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/34771039&rfr_iscdi=true